After more than 20 years, a major arthritis drug is about to face cheaper competition


When a pharmaceutical drug has been on the market a while, it’s supposed to go generic and the price is supposed to go down. For blockbuster arthritis drug Humira, that hasn’t happened — until now.

Read More at NPR

Check Also

Senate looks at labor laws which unions say interfere with workers’ right to organize

Unions say labor law is too weak, allowing companies to illegally interfere with workers’ right …